docetaxel anhydrous has been researched along with ascorbic acid in 5 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 45,261 | 2,497 | 11,176 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | ascorbic acid (IC50) |
|---|---|---|---|
| Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
| Urease | Canavalia ensiformis (jack bean) | 8.59 | |
| Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Danielová, V; Gut, I; Holubová, J; Klucková, H; Soucek, P | 1 |
| Aigner, A; Czubayko, F; Frömberg, A; Gutsch, D; Schulze, D; Vollbracht, C; Weiss, G | 1 |
| Chen, X; Dai, Y; Fan, A; Feng, F; Guo, C; Li, J; Li, N; Lu, Y; Zhao, D | 1 |
| Fu, Q; Guo, L; Hai, L; Wu, Y; Xiao, W; Yue, Q; Zhang, L; Zhao, Y | 1 |
1 review(s) available for docetaxel anhydrous and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for docetaxel anhydrous and ascorbic acid
| Article | Year |
|---|---|
Cytotoxicity of cyclophosphamide, paclitaxel, and docetaxel for tumor cell lines in vitro: effects of concentration, time and cytochrome P450-catalyzed metabolism.
Topics: Animals; Ascorbic Acid; Catalysis; Cyclophosphamide; Cytochrome P-450 Enzyme System; Dimethyl Sulfoxide; Docetaxel; Dose-Response Relationship, Drug; Lipid Peroxidation; Male; Microscopy, Fluorescence; Paclitaxel; Rats; Rats, Wistar; Taxoids; Time Factors; Tumor Cells, Cultured | 2000 |
Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs.
Topics: Antineoplastic Agents; Apoptosis; Ascorbic Acid; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dehydroascorbic Acid; Docetaxel; Drug Synergism; Epirubicin; Humans; Irinotecan; Male; Organoplatinum Compounds; Oxaliplatin; Prostatic Neoplasms; Taxoids; Vinblastine; Vinorelbine | 2011 |
Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Ascorbic Acid; Cell Line, Tumor; Docetaxel; Drug Compounding; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Liposomes; Liver Neoplasms, Experimental; Mice, Inbred ICR; Nanocapsules; Particle Size; Pharmaceutical Vehicles; Taxoids; Tumor Burden | 2016 |
Ascorbic acid-modified brain-specific liposomes drug delivery system with "lock-in" function.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Brain; Docetaxel; Drug Compounding; Glucose Transporter Type 1; Humans; Liposomes; Mice; Molecular Structure; Serum Albumin, Bovine; Sodium-Coupled Vitamin C Transporters; Structure-Activity Relationship; Surface Properties; Thiamine; Tissue Distribution | 2019 |